It’s no secret that achieving a truly targeted effect is the holy grail of the cannabis industry, but how close are we to making this a reality? Are designer cannabis products on the horizon? 

Here to help answer this is Chris Emerson, co-founder and CEO of a unique company known as Level that’s working to disrupt the cannabis industry with products precisely tailored to every individual and every occasion.

Learn more at https://www.levelblends.com 

Key Takeaways:

• Chris’ background in chemistry and how it led him to the cannabis space
• An inside look at Level and its mission to provide a tailored cannabis experience to every patient and consumer
• How Chris’ extensive background in science allows him to think about cannabis products differently than most entrepreneurs in the industry
• Why Level sources its oils from strains high in CBD, CBG, and THCV and how this enhances the overall effect for consumers
• Chris’ efforts to find rare and unique cannabinoids for Level’s products and his discoveries to date
• A deep dive into Level’s tablinguals and pax vaporizer pods
• Chris’ work at Level determining new uses for cannabinoids, including everything from stimulants to hangover cures
• New and exciting initiatives at Level and Chris’ insight on what the cannabis industry will look like in the next 5-10 years

Where do you start the search for your next cannabis product? Here to tell us how customers are starting their cannabis search (and what they’re searching for) is Dan Nelson of Wikileaf, the industry’s leading price comparison platform.

Learn more at https://www.wikileaf.com 

Key Takeaways:

• Dan’s background in cannabis and how he came to start Wikileaf
• An inside look at Wikileaf and its mission to help customers save money while making informed purchases
• Consumer trends and the types of products that are gaining traction
• Differences and similarities between Wikileaf and Leafly
• How Wikileaf creates perceived value to attract buyers without cutting price
• Dan’s advice to entrepreneurs on how to go to market to ensure the best chance of success
• Wikileaf’s ad policy for brands looking to stand out in a crowded market
• Where Dan sees dispensary offerings and consumer preferences heading in the months ahead

As cannabis cultivators pour billions of dollars into developing cutting-edge, efficient grows, we need to ask: is there a hidden disruptor that could steal their business in the years ahead?

Here to help us answer this is Kevin Chen of Hyasynth Bio, one of just a few companies experimenting with non-plant-derived cannabinoids.

Learn more at https://hyasynthbio.com 

Key Takeaways:

• Kevin’s background in cannabis and how he came to start Hyasynth Bio
• An inside look at Hyasynth Bio and its work with non-plant-derived cannabinoids
• A deep dive into biosynthesis and how Hyasynth Bio uses this process to grow cannabis compounds inside yeast cells
• How Hyasynth Bio has successfully overcome challenges with biosynthesis
• The history of biosynthesis and cannabis and where Kevin sees this relationship evolving in the years to come 
• The different types of end products we’ll start to see for sale in dispensaries that use biosynthesis
• How biosynthesis will affect cannabis prices
• Hyasynth Bio’s intellectual property strategy and how Kevin manages the company’s patents
• The traditional cannabis companies that are investing in biosynthesis
• Where Kevin sees cannabinoid biosynthesis heading in the next 3-5 years

It’s no secret cannabis cultivation is going global. Here to tell us why and how he’s expanding into Africa is Jonathan Summers of EXMceuticals, a medical cannabis firm that aims to become the largest volume, lowest cost producer of wholesale cannabis in the world.

Learn more at https://exmceuticals.com (CSE: EXM) (FSE: A2PAW2) 

Key Takeaways:

• Jonathan’s background in cannabis and how he came to be Executive Chairman of EXMceuticals
• An inside look at EXM and its mission to become the largest volume, lowest cost producer of wholesale cannabis ingredients
• Jonathan’s insight on Brexit and how it will affect London as a financial hub
• Why EXM cultivates cannabis in Africa before processing, selling, and distributing in Portugal 
• What cannabis cultivation in Africa could mean for the country’s economy and job market
• Differences between the cannabis industry in Europe versus the U.S. 
• The products Jonathan foresees gaining traction in Europe over the next few years 
• What Dixie Elixir’s Tripp Keber is bringing to the table as a strategic advisor for EXM
• How EXM is working to support African communities through nonprofit funds and increased employment
• Inspiration Jonathan draws from lectures given by English philosopher Alan Watts
• Where Jonathan sees EXM and cannabis heading in the next few years